Publication | Closed Access

Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

Histone ModificationsChromatinHematological MalignancyChromatin RemodelingMedicineAcute Myeloid LeukemiaHistone Deacetylase InhibitorsMixed-phenotype Acute LeukemiaMalignant Blood DisorderAnti-leukemia TherapyPharmacologyCell BiologyEpigeneticsCancer ResearchMyeloid Neoplasia